Janet M. Dillione's most recent trade in CorMedix Inc was a trade of 25,000 Common Stock done . Disclosure was reported to the exchange on Jan. 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CorMedix Inc | Janet M. Dillione | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 25,000 | 78,473 (0%) | 0% | 0 | Common Stock | |
| CorMedix Inc | Janet M. Dillione | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Janet M. Dillione | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Janet M. Dillione | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Janet M. Dillione | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Janet M. Dillione | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2020 | 4,770 | 4,770 | - | - | Phantom Stock |